UBS Group Issues Pessimistic Forecast for Owens & Minor (NYSE:OMI) Stock Price

Owens & Minor (NYSE:OMI - Get Free Report) had its price target reduced by UBS Group from $28.00 to $25.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. UBS Group's price target suggests a potential upside of 112.22% from the stock's previous close.

OMI has been the subject of a number of other research reports. Robert W. Baird reduced their price objective on Owens & Minor from $19.00 to $14.00 and set a "neutral" rating for the company in a research report on Tuesday. StockNews.com cut Owens & Minor from a "buy" rating to a "hold" rating in a research report on Monday, August 26th. Barclays cut their price target on Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating for the company in a report on Tuesday. JPMorgan Chase & Co. cut their price target on Owens & Minor from $22.00 to $18.00 and set an "underweight" rating for the company in a report on Wednesday, August 21st. Finally, Citigroup cut their price target on Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a report on Tuesday. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $18.50.

Owens & Minor Stock Down 1.8 %

Shares of OMI stock traded down $0.22 during mid-day trading on Tuesday, hitting $11.78. The company's stock had a trading volume of 1,273,269 shares, compared to its average volume of 834,960. Owens & Minor has a 52-week low of $11.42 and a 52-week high of $28.35. The business has a 50-day moving average price of $14.54 and a 200 day moving average price of $16.19. The company has a debt-to-equity ratio of 2.17, a quick ratio of 0.51 and a current ratio of 1.09. The stock has a market cap of $908.24 million, a price-to-earnings ratio of -21.04, a PEG ratio of 0.43 and a beta of 0.41.

Owens & Minor (NYSE:OMI - Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.42 EPS for the quarter, beating analysts' consensus estimates of $0.41 by $0.01. The company had revenue of $2.72 billion during the quarter, compared to analysts' expectations of $2.68 billion. Owens & Minor had a positive return on equity of 14.66% and a negative net margin of 0.40%. Owens & Minor's revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.44 earnings per share. Research analysts predict that Owens & Minor will post 1.57 EPS for the current fiscal year.

Institutional Investors Weigh In On Owens & Minor

A number of hedge funds have recently modified their holdings of OMI. Vanguard Group Inc. grew its holdings in Owens & Minor by 1.9% during the 1st quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company's stock worth $242,459,000 after acquiring an additional 162,182 shares in the last quarter. Deerfield Management Company L.P. Series C boosted its holdings in shares of Owens & Minor by 30.6% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company's stock valued at $86,014,000 after buying an additional 1,493,852 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Owens & Minor by 1.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,534,204 shares of the company's stock valued at $61,213,000 after buying an additional 76,599 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Owens & Minor by 16.5% in the 2nd quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company's stock valued at $16,829,000 after buying an additional 176,250 shares in the last quarter. Finally, Dana Investment Advisors Inc. boosted its holdings in shares of Owens & Minor by 35.8% in the 2nd quarter. Dana Investment Advisors Inc. now owns 609,040 shares of the company's stock valued at $8,222,000 after buying an additional 160,682 shares in the last quarter. 98.04% of the stock is currently owned by institutional investors and hedge funds.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.